Wealthfront Advisers LLC Cassava Sciences Inc Transaction History
Wealthfront Advisers LLC
- $120 Billion
- Q4 2024
A detailed history of Wealthfront Advisers LLC transactions in Cassava Sciences Inc stock. As of the latest transaction made, Wealthfront Advisers LLC holds 25,444 shares of SAVA stock, worth $57,757. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,444Holding current value
$57,757% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SAVA
# of Institutions
192Shares Held
13.7MCall Options Held
2.97MPut Options Held
6.55M-
Black Rock Inc. New York, NY3.22MShares$7.31 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.52MShares$5.73 Million0.0% of portfolio
-
State Street Corp Boston, MA1.16MShares$2.64 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.01MShares$2.29 Million0.0% of portfolio
-
Gallacher Capital Management LLC Lone Tree, CO580KShares$1.32 Million7.83% of portfolio
About CASSAVA SCIENCES INC
- Ticker SAVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,097,900
- Market Cap $91M
- Description
- Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...